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The best teachers are those who show you where to look, 
but don´t tell you what to see. (Alexandra K. Trenfor)
The scientific man does not aim at an immediate result. He does not expect that his 
advanced ideas will be readily taken up. His work is like that of the planter –for the 
future. His duty is to lay the foundation for those who are to come, and point out the 
way. He lives and labors and hopes with the poet who says:
              (Nicola Tesla)
Un país que desprecia la verdad está condenado a la decadencia. (Harry G. Frankfurt)

The augmenting number of upper gastrointestinal (UGI) procedures, specially due to bariatric surgery, 
entails an expected increase in the absolute number of surgical complications. Among the most 
devastating complications is that of a postsurgical leak, increasing morbidity and mortality thus 
affecting long-term survival rate and treatment’s cost. Consequently nowadays we think it should be 
considered like a real public health problem. Incidence and risk factors are well described in literature. 
Surprisingly, a definition for this entity nor a management algorithm has not been described yet.
Between 2003 and 2013, 1.856 patients underwent an UGI operation in our center: 121 gastrecto-
mies (total: 58 subtotal: 63); 1.654 gastric bypass; and 81 sleeve gastectomies. 15 (0,08%) patients 
with confirmed intraabdominal post-surgical leak were reported (10 acute; 5 chronic). Diagnosis 
methods, management and complications were analized.
Intraabdominal anastomotic leak (IAAL) has been defined in our study as a disruption of esophago- 
jejunal, gastro-jejunal or jejuno-jejunal anastomosis, as well as on the staple line and paraanastomotic 
abscesses seen on radiological images.
Early diagnosis was possible due to high index suspicion. Identification of patients with severe sepsis 
or septic shock was provided by SIRS classification. A CT scan with oral and/or intravenous contrast, 
stablished evidence of leak in 13 patients. Endoscopy verified radiological findings and assessed 
severity in 9 patients. In 5 cases it was performed before surgery. No differences in rates in reoper-
ation, leakage and postsurgical complications were described in this group. Imminent exploratory 
laparoscopy was performed in 2 hemodynamic unstable patients.
Treatment was established promptly combining endoscopical, surgical and/or radiological techniques. 
Management options were determined by hemodynamic conditions of the patient and the charac-
teristics of leakage to assure enteral nutrition as soon as possible. Conservative management was 
carried out in 4 patients, healing 3 of them. 11 patients submitted surgical treatment (8 laparoscopies; 
1 urgent laparotomy; 2 elective surgeries). Stent was deployed in 8 patients (sealing rate: 62,5%).
Abstract
Life-threatening complications requiring ICU management (Clavien-Dindo IV) (33.3%) were more frequent 
in patients with surgical management. One (6,6%) patient died. Patients with conservative management 
had short intensive care course (10 versus 13 days) and hospital stay (15 versus 26 days). 
Early diagnosis of IAAL is paramount and it should not be based on clinical suspicion alone. Therefore 
endoscopic exploration should be performed when possible, allowing early diagnosis, providing infor-
mation of anastomosis’ morphologic characteristics that will help accurate the best management. 
Eventually treatment can be done at the same time. 
Management by a multidisciplinary team, combining endoscopical, surgical and radiological tech-
niques is the best strategy to reduce time until leak healing. It is important to considerate severity and 
location of the leak as well as the day of appearance. In hemodynamic stable patients, conservative 
management is effective and can obviate a reintervention, thereby avoiding postoperative compli-
cations. Goals are effective drainage, covering dehiscence by an endoscopic stent and renutrition. 
Endoscopical treatment can heal or may help to make a chronic leak until a definitive surgery can be 
performed in a patient’s optimal clinical and nutritional status.
Hemodynamic unstable patients need a prompt surgical repair. Laparoscopic approach allows 
evaluation of anastomosis’ characteristics, consents a peritoneal lavage and positioning effective 
drains. Laparotomy remains anecdotal for hemodynamic unstable non-responding patients excluded 
of mini-invasive treatment, in order to diminish disadvantages and complications of operative treatment.
We suggest applying IAAL definition in forthcoming studies on UGI surgery to homogenise reporting 
of outcomes thus facilitating comparison of the results from different studies so in the future this 
concept can be standardize. To conclude, a management algorithm is proposed.
Abstract
Debido al aumento de procedimientos supramesocólicos, especialmente por la cirugía bariátrica, 
cabe esperar un incremento del número total de sus complicaciones. Entre ellas se encuentra la 
dehiscencia anastomótica siendo una de las complicaciones más devastadoras, que incrementa la 
morbi-mortalidad, la tasa de supervivencia a largo plazo y el coste, pudiendo llegar a considerar este 
evento como un verdadero problema de salud pública. Su incidencia y factores de riesgo están bien 
descritos en la literatura. Por el contrario, no existe una definición ni tampoco un algoritmo de manejo.
Entre 2003 y 2013, en el CHL, 1.856 pacientes fueron sometidos a una cirugía supramesocólica en 
CHL: 121 gastrectomías por cáncer ( totales: 58  subtotales: 63); 1654 bypass gástrico; y 81 tubu-
laduras. 15(0.08%) pacientes fueron diagnosticados de dehiscencia anastomótica intraabdominal 
(10 agudas; 5 crónicas). Se analizó el diagnóstico, el manejo y las complicaciones derivadas de éste.
La dehiscencia anastomótica intraabdominal tras cirugía supramesocólica (IAAL) se definió como la 
discontinuidad en las anastomosis esófago-yeyunal, gastro-yeyunal o yeyuno-yeyunal, así como en la 
línea de grapado y los abscesos perianastomóticos descritos en las pruebas de imagen.
El diagnóstico temprano fue posible a un alto índice de sospecha. La identificación de paciente 
con sepsis severa o shock séptico fue realizada con el sistema de clasificación SIRS. El TAC con 
contraste oral y/o intravenoso demostró la dehiscencia en 13 pacientes. La endoscopia verificó los 
hallazgos radiológicos y evaluó el grado de severidad en 9 pacientes. En 5 casos se realizó previo a la 
cirugía. En este grupo no se evidenciaron diferencias en la tasa de reintervención ni en las complica-
ciones postoperatorias. Tampoco desarrollaron nuevas dehiscencias posteriormente. Se realizó lapa-
roscopia exploradora diagnóstica urgente en 2 pacientes debido a la inestabilidad hemodinámica.
Se instauró tratamiento precoz combinando técnicas endoscópica, quirúrgicas y/o radiológicas. 
Las opciones de manejo estuvieron determinadas por la situación hemodinámica del paciente así 
como por las características de la dehiscencia, para garantizar la nutrición enteral lo antes posible. 
Resumen
Resumen
Cuatro pacientes se manejaron de forma conservadora, curando a 3 de ellos. Once pacientes se 
trataron quirúrgicamente (8 laparoscópia; 1 laparotomía urgente; 2 cirugía electiva). Ocho pacientes 
fueron subsidiarios de colocación de stent (tasa de sellado del 62,5%).
Las complicaciones que precisaron manejo en UCI (Clavien-Dindo IV) (33,3%) fueron más frecuentes 
en el grupo de pacientes con manejo quirúrgico. Un paciente falleció (6,6%). Los pacientes con manejo 
conservador tuvieron menor estancia media en UCI (10 versus 13 días) y hospitalaria (15 versus 26 días).
El diagnóstico temprano es fundamental y no puede estar basado únicamente en la sospecha clínica. 
En estos casos se debería realizar una exploración endoscópica. Ello proporciona el diagnóstico precoz, 
aporta información sobre las características morfológicas de la anastomosis (perfusión tisular, tamaño), 
que ayudarán a escoger el mejor manejo. Eventualmente, permitiría su tratamiento en el mismo acto.
El manejo por un equipo multidisciplinar combinando técnicas endoscópicas, quirúrgicas y 
radiológicas es la mejor estrategia para disminuir el tiempo hasta la curación de la dehiscencia. 
Es importante valorar la severidad, la localización y el día de aparición de la dehiscencia. En pacientes 
estables hemodinámicamente, el manejo conservador es efectivo y puede evitar la reintervención. 
Los objetivos son: un drenaje efectivo, cubrir la dehiscencia con un stent y reintroducir la nutrición vía 
oral lo antes posible. El tratamiento endoscópico puede curar o puede hacer que la dehiscencia sea 
crónica hasta poder instaurar un tratamiento quirúrgico definitivo cuando las condiciones clínicas y 
nutricionales del paciente lo permitan. 
Los pacientes con inestabilidad hemodinámica necesitan un manejo quirúrgico precoz. El abordaje 
laparoscópico permite la evaluación de las características de la anastomosis, realizar un lavado 
de la cavidad peritoneal y la colocación de drenajes efectivos. La laparotomía se limita a casos 
anecdóticos, pacientes inestables no respondedores excluidos del tratamiento mini-invasivo, para 
disminuir las complicaciones y desventajas derivadas del tratamiento quirúrgico. 
Resumen
Se sugiere la aplicación de la definición IAAL en futuros estudios de cirugía supramesocólica para 
que los resultados sean homogéneos y así facilitar la comparación de resultados entre los diferentes 
estudios que más adelante permitan estandarizar este concepto. A modo de conclusión se propone 
un algoritmo de manejo.
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3
Biliary, pancreatic and colorrectal leak is a concept well defined in the literature. Authors have reached 
a consensus, standardized diagnostic algorithms and severity degrees. The implementation of uniform 
definitions of anastomotic leak enables surgeons to compare and to improve treatments’ options. 
Nevertheless comparable consensus definitions for leaks in esophago-jejunal anastomosis (EJAL), 
gastro-jejunal anastomosis (GJAL) or following small bowel anastomosis have not been established.1 
In spite of the fact that there are different surgical techniques for the upper gastrointestinal (UGI) tract 
where the gastrointestinal anastomosis vary considerably there are common and general concepts for 
diagnosis and management.
1.1. CURRENT STATUS
Surgery is the only curative treatment for gastric cancer and the most effective and cost-effective treat-
ment for morbid obesity 2 allowing a ponderal reduction and its long term maintenance, decreasing up to 
one third of the global mortality (due to cancer and cardiovascular pathologies), respiratory diseases and 
quality of life as well as resolution of the clinical manifestations of type 2 diabetes or its improvement.3-7
In 2009, approximately of 350 surgical intestinal actions, 2 over 10 did not have anastomosis neither 
sutures in France.8 The recent improvement of laparoscopic approach, which requires automatic 
devices for sutures and anastomosis, has determined modifications in many surgical practices, 
specially in gastric surgery.8 Industries’ recent development of the automatic suturing devices and 
its increased use in anastomosis in the GI tract, has achieved a marked reduction in EJAL.9,10 But the 
multiplying number of procedures, especially due to bariatric surgery, entails an expected increase 
in the absolute number of surgical complications.2 French National Surgery Annual Report of 2009 
reveals that 5,666 gastrectomies were performed in 2006: 2,393 (42%) partial gastrectomies, 1,691 
(30%) total gastrectomies and 1,225 (22%) atypical resections; that year 12% of the gastrectomies 
were done by laparoscopy.8
Bariatric procedures are among the most commonly performed gastrointestinal operations today.11 
A bariatric surgery worldwide survey in 2011 calculated the global total number of procedures in 
2011 was 340,768. The most commonly performed procedures were:
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- Roux-en-Y gastric bypass (RYGBP) 46.6%
- Sleeve gastrectomy (SG) 27.8%
- Adjustable gastric banding (AGB) 17.8%
- Biliopancreatic diversion/duodenal switch (BPD/DS) 2.2%
The global trends from 2003 to 2008 to 2011 (figure 1) showed a decrease in RYGB (65.1 to 49.0 to 
46.6%) and a marked increase in SG (0.0 to 5.3 to 27.89%); BPD/DS declined (6.1 to 4.9 to 2.1 9%); 
USA/Canada performed the largest number of operations (101,645), followed by Brazil (65,000), 
France (27,648), Mexico (19,000), Australia and New Zealand (12,000), and the UK (10,000). 
No other nation performed 10,000 or more operations.11
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Figure 1: Trends in numbers of bariatric procedures worldwide: 2003 to 2011. 11 
INCIDENCE DATA
EJAL rate vary from 0 to 26% with an average of 5-8% in major recent series.12 In bariatric surgery 
the global incidence average is around 3%. Leak rates after laparoscopic gastric bypass (LGBP) 
vary from 0 to 5.6% in major series and despite some authors conclude that there are no differences 
between laparoscopy and standard approach,13 others conclude that leak rate was significantly 
lower in laparoscopic compared with open GBP (0.3% vs. 2.0%, P < .01).14
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There are four potential sites of anastomotic leak after Roux-en-Y LGBP (figure 2): at the GJA, the 
gastric pouch staple line, the gastric remnant staple line and the JJA. The frequency with which 
leaks occur is not specified in most studies. The study from Ballesta and collegues 15 reported their 
experience regarding bariatric leaks with their specific location: 68% at the GJA, 10% at the gastric 
pouch staple line, 3% at the remnant gastric staple line, 5% at the JJA and the remaining 14% at 
combinations of these. In general, it is accepted that the GJA is the most site prone to leak, because 
is the most noted site in many large series.2
Figure 2: Location of staple line leaks after Roux-en-Y gastric bypass of Ballesta and cols.15 
The remaining 14% were combinations of these.
10%
3%
5%
68%
Leak rate after laparoscopic sleeve gastrectomy (LSG) fluctuates between 0 and 7%.16,17 There does 
appear to be a higher leak rate in patients with a BMI>50 kg/m2.18 It is frequently located at the proximal 
portion of the staple line, in the esophagogastric junction (EGJ) because this part is thinner than the rest 
of the stomach wall.16 Elariny et al 19 demonstrated that the stomach has different thickness throughout 
with the fundus being the thinnest at approximately 1.7mm.
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MORBIDITY AND MORTALITY DATA 
Even though surgical complications and mortality rate for gastric cancer have significantly decreased 
over the past years, they are still considered high.20 Anastomotic leak rate is higher for total gastrec-
tomies than for partial ones. The adjusted 30-day mortality rate is Europe is higher in the Netherlands 
(6.9%), Sweden (3.5%) and Denmark (4.3%).21
Anastomotic leakage after gastric cancer surgery is the most devastating complication and an inde-
pendent prognostic factor for long-term survival in patients with gastric cancer.22 It also entails a 
reduction in patients’ quality of life, a longer hospital stay, higher hospital costs and a higher mortality 
rate,12 which ranges from 25 to 75%.23
In relation with bariatric surgery contradictory data have been reported on mortality rates and it 
depends on the population under the study, the type of intervention and the characteristics of the 
institutions involved.24 The retrospective review done by Kohnet et al 25 over 100,000 procedures 
in the USA between 1998 and 2006, revealed a mortality rate lower than 0.2%. It was statistically 
related with the number of cases per year per surgeon and the type of intervention (higher mortality 
in the case of malabsorptive techniques and lower in laparoscopic gastric banding). Post-surgical 
leaks produce a 2-fold increase in mortality and 6-times increase in hospital stay compared with 
patients without leaks.2 It is the second cause of death after pulmonary embolism, and both of them 
are responsible of more than 50% of deaths in patients with bariatric surgery.13 Patients who develop 
leakage during the hospital stay have higher incidence of surgical site infection, sepsis, embolic 
events, internal hernias, bowel obstruction and renal and respiratory failure than those who do not 
develop this complication.26
1.2. RISK FACTORS
Causes are not well defined neither for benign and malignant disease.2 Table 1 summarizes anasto-
motic leak risk factors after gastric surgery for cancer published in larger series. There is still controversy 
about the nutritional status, presence of diabetes, surgeon experience and type of reconstruction.
introduction
7
Patient Related Surgery Related
Hb A1C > 7
 10 Intraoperative technical mistake 10,22
Renal insufficiency 10 Prolonged surgical time 10,27
Pulmonary insufficiency 27 Splenectomy 12
Cardio-pulmonary preoperatory status 12
Diabetes Mellitus 10 Surgeon’s experience 10
Malnutrition 12 Type of reconstruction 27
Obesity 12
Table 1: Risk factors for IAAL after gastric surgery for cancer (controversial factors are shaded).
Migita 10 - Deguchi 27 - Sierzega 12 - Nagasako 22
Leak risk factors after bariatric surgery have been more studied. The increased number of proce-
dures performed allows studying large series and having conclusions statistically significant that are 
exposed on table 2. We can summarize that prevention of leak depends on the strict patient selection 
and accurate surgical tecnique.28 In the other hand, there are prospective studies that conclude that 
the incidence of staple-line leaks appears to be independent of the number of LGBP performed.29
Patient Related Surgery Related
> 45 years 2,30 Revisional surgery 32
Men 2,30,32 Open surgery 30
BMI > 50 kg/m2 30,32 Surgeon’s experience 31
Obstructive Sleep Apnea (OSA) 2,30 Non standardized technique 32
Arterial hypertension 32 Ischemic tissues 2
Comorbililities 32 Anatomic variabilities 2
Previous abdominal surgery 32 Non tension-free anastomosis 2
Recent cardiac disease 30 Bougie size >40-Fr 16
DM in treatment with OADs 30 Staple height 2, 16
Ascites 30 Fibrin sealant 13
Corticotherapy 30
Table 2: Risk factors for IAAL after bariatric surgery (controversial factors are shaded)
Morales 2 - Kahn 30 - Griffith 31 - González 32 - Aurora 16 - Harakeh 13
1.3. PHYSIOPATHOLOGY AND BIOMECHANICS OF STAPLING 
There are many causes of staple-line leaks but Baker 33 summarizes it in two categories: mechanical/
tissue causes and ischemic causes. In both cases, intraluminal pressure exceeds the strength of the 
tissue and the staple-line, resulting in a leak. Classic ischemic leaks are described to occur 5-7 days 
postoperatively when the wound healing is between the inflammatory and fibrosis phases. In their 
introduction
8
clinical experience and in their literature review, they observe that the vast majority of leaks occurred 
in the first two days following surgery. During the reoperation they did not see evidence of ischemia 
but instead found evidence of staple-line failure in well-perfused tissue. Therefore they believe that 
most leaks are due to mechanical/tissue issue and that true ischemic leaks are rare.33
The diverse staple cartridges are designed for different tissue thickness to allow tissue apposi-
tion, hemostasis while avoiding significant ischemia and tissue destruction.33 Human tissues are 
considered biphasic because of their liquid and solid components. The intra and extra-cellular fluids 
components influence the tissue, so that elongation (tissue creep) occurs when crushing force 
is applied. When subjected to an applied displacement, stress relaxation occurs. At some point, 
increasing compression will produce excess tissue shear or tensile stress that results in tearing of 
tissues. The phenomena of tissue creep, stress relaxation, and shear or tensile stress are dependant 
upon one common factor: time.33 Optimal stapling then would consist of allowing adequate time for 
tissue compression and creep while not producing excessive tensile stress.34
Different studies were made to determine the optimal pressures; they were found to be 8 g/m2 for 
gastric tissue and 6 g/m2 for the esophagus or intestines. The results demonstrated that optimal 
pressure when applied, caused good apposition and negligent structural modifications with no long-
term tissue disruption or aggravation.35
1.4. CLINICAL FEATURES 
Depending on the anastomotic leak location, time to diagnosis and time to establishment of treat-
ment it may have a different clinical presentation with diverse systemic repercussion (e.g. peritonitis 
and/or septic symptoms and signs, biliary or intestinal drainage). There is a discrepancy between 
severity and lacking symptoms in bariatric patients, hence surgeon has to keep a high suspicion to 
identify and diagnose this complication.28
In contrast to non-obese population, bariatric patients with leak often present without fever, leuko-
cytosis, or abdominal pain. In many patients the only sign is sustained tachycardia.2 Gonzalez and 
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collegues 32 reported that tachycardia (>100 bpm) was the only consistently present indicator in 72% 
of patients with a confirmed anastomotic leak; fever and leukocytosis was present in 72% and 42% 
respectively. Carruci et al 36 also noted that the most common symptoms after tachycardia (92%) 
were nausea and vomiting (81%) in the study group.
For Guirao et al 37 the prompt diagnosis of severity in patients with intraabdominal infection and the 
early treatment with antibiotics is related to a better prognosis in severe intraabdominal infection. 
To that end they propose a simple classification of the systemic inflammatory response syndrome 
(SIRS) that can be obtained easily on the bedside of the patient (Table 3). They have demonstrated 
its utility in identification of severe sepsis and septic shock remarking a good correlation between 
mortality rate in patients with severe sepsis.
SIRS (2 or more of these criteria)
Temperature > 38º or <36º C
Heart rate > 90 bpm
Respiratory rate >20 breaths per minute
White blood cell count >12,000 l/mm3 or < 4,000 l/mm3 or >10% band neutrophils
Mild-moderate intraabdominal infection Severe intraabdominal infection
SIRS with venous lactate ≤ 2 mmol/l
Presence of 4 criteria de SIRS or
SIRS with 1 organ failure (severe sepsis) or
Hypotension requiring vasoactive drugs (septic shock) or
Venous lactate >2 mmol/l
Table 3: SIRS criteria and evaluation of severity in intraabdominal infection. 37
1.5. DIAGNOSIS
Running time between anastomotic leak and treatment establishment, endoscopic or surgical, is one 
of the most critical prognostic factors.38 Early detection and immediate adequate treatment are the 
most important factors for a favorable outcome. Delayed diagnosis is associated with a high risk of 
abdominal collection, sepsis and treatment failure.39
There are several options varying from the less invasive exams like CT scan with oral contrast, 
esophagogram with oral contrast and blue methylene; to more aggressive, like exploratory lapa-
roscopy or laparotomy. More recently the role of endoscopy is getting defined for the diagnosis of 
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anastomotic leaks after UGI surgery. Summarising, patient’s hemodynamic status is going to deter-
mine the diagnostic method of IAAL. 
1.6. PRINCIPLES OF TREATMENT
Management of IAAL after UGI surgery is not well defined in literature and may change from one 
group to another and depends also on the first surgery. Csendes and colleagues in the early ‘90s 
settle the basis of non-operative treatment in EJAL that later Lang and colleagues 40 in 2000 ratify, 
concluding that conservative treatment with a naso-intestinal tube and percutaneous drainage of 
intraabdominal abscesses is realistic for anastomotic leak.
Nowadays there are described different treatment options: laparoscopic/laparotomy urgent surgical 
exploration (washing and drain, discontinuity and resection, diversion, re-anastomosis); conservative 
treatment with broad-spectrum antibiotics, percutaneous drain, enteral/parenteral nutrition and naso-in-
testinal tube. As a principle anastomotic leak treatment must be multidisciplinary, must be done as soon 
as possible and will depend on patient’s clinical and/or hemodynamic conditions. Hemodynamically 
unstable patients with anastomotic leak are susceptible to a more aggressive treatment while patients 
with a scarce clinical repercussion will profit of a conservative treatment or an observing attitude. 
Both surgical and non-operative treatment are associated with high mortality rates and long intensive 
care unit and hospital stays. In the search for an optimized management, the endoscopic placement 
of stents has been introduced in the management of anastomotic leakages in the past decade.41-44 
The use of self-expandable metal stents (SEMS) is well established in the palliative treatment of 
patients with an upper GI neoplasm or tracheo-esophageal fistula.45
Stents are capable to effectively seal leaks while they protect the bowel mucosal wall at the same 
time that healing takes place when an effective drain is deployed.46 The retrieval after temporary 
therapeutic use has not been reasonably possible until the development of covered stents. It can 
be removed 4 to 6 weeks after, once sealing of the leak is confirmed with a radiological test (transit 
or CT scan with oral contrast).39,45 This has opened a pathway for new therapeutic strategies 47 
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reported in literature as cases and short series with promising results; the disadvantages are that 
they are small, heterogeneous, non randomized cohorts.45 The main drawbacks are stent migration 
and tissue in or over-growth, both of which need a repeated intervention.38 There are multiple types 
available (table 4) from various enterprises that differ on the material they are made of, design, luminal 
diameter, radial force exerted, flexibility and degree of shortening after use.48
Other encouraging endoscopical treatments recently published have been: endoscopic clips, vicryl 
plugs and fibrin sealants (FS) injections and argon plasma endoscopical treatments.15,49-59 
Type Characteristics Commercial names
SEMS Metallic
Stainless steel or nitinol (alloy of nickel and titanium with 
a thermic memory) 60 
Inert, resistant to corrosion 60
Non allergenic (can be placed in patients allergic to nickel) 60
Induces an inflammatory fibrotic response that reduces 
the risk of migration 60
Uncovered (SEMS) 
Main drawback: tissue growthàcan make removal difficult
Generally used in palliative treatment
Wallflex-Ultraflex-(Boston)
Evolution (Cook)
Covered
Silicon or polyurethane
Main inconvenient: migration
Partially
Usually with wide endings not covered that help endolu-
minal fixation 60 
First therapeutic option for anastomotic leaks 60
Wallflex (Boston)
Osiris (ABS-Bolton)
Hanaro stent (Life Europe)
Fully
Recently approved by the FDA 38
Potentially associated with increased risk of migration 38 
Published data are awaited 38
HV stent (ABS- Bolton)
SEPS Plastic
Polyurethane
Conceived to prevent mucosal proliferation, tracheo-oe-
sophageal fistula and strictures 61 
Require clips or suturing to guarantee its position despite 
a proximal widening 62 
Highest migration rate 61
Similar healing time (80-90%) 61
Low mortality-related leak rates 61
Polyflex (Boston)
Table 4: Stents and their characteristics
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1.7. OBJECTIVES
The aims of this study are to:
- Propose a definition of intraabdominal anastomotic leak after UGI surgery.
- Establish incidence in our center. 
- Describe our surgical techniques for anastomosis in the UGI tract.
- Describe the spectrum of clinical presentations, use and efficacy of diagnostic exams.
- Describe our management and results, and compare them to international reference series. 
- Propose a flowchart algorithm for its treatment.


material and 
methods
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2.1. PATIENTS
A retrospective review was made in the prospective database of the patients submitted to an UGI 
surgery at Centre Hospitalier of Luxembourg (CHL) between January 2003 and April 2013. Patients 
with an IAAL were identified and included in this study. Information obtained from hospital records to 
describe patients, clinical presentation, diagnosis and management was collected: 
• Patient data: age, sex, BMI, comorbilities, leak location, previous surgery done outside CHL, 
preoperative treatment (neoadjuvant treatment), type of anastomosis, margin borders affection 
if malignancy.
• Diagnosis: symptoms and signs (fever, pain, heart rate, respiratory rate, peritonism, MOF, 
drain); laboratory variables (WBC count, CRP, procalcitonine); diagnosis exam (thorax Rx, blue 
of methylene, CT scan with oral and intravenous contrast, diagnostic laparoscopy or lapa-
rotomy); diagnostic sequence. 
• Treatment: reoperation, number of reinterventions, surgery done the second time, placement 
of percutaneous drain, stent, clip, fibrin sealant, time to healing. 
• Complications: they were classified using the Clavien-Dindo classification 63,64 (see appendix A). 
• Hospital admission: admission in intensive care unit, hospital admission.
2.2. DEFINITION OF INTRAABDOMINAL ANASTOMOTIC LEAK AFTER UPPER GASTRO-
INTESTINAL SURGERY 
Anastomotic leak was defined as a disruption on the staple line and/or a disruption of the EJA, GJA 
and JJA. It was also considered as an anastomotic leak the para-anastomotic abscesses seen on 
radiological images, although communication to anastomosis could not be seen with oral contrast. 
They were classified regarding to:
• Time of appearance after sugery: intraoperative, acute (1-11 days after surgery) or chronic 
(12 or more days after surgery).50
• Hemodynamic stability of the patient: stable, unstable.
• Anatomic location: staple line, EJA, GJA and JJA.
• Morphological characteristics founded in endoscopy: total wall necrosis, circumference 
defect <70% or >70%.
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2.3. SURGICAL TECHNIQUES 
Nowadays our surgical techniques are standardized and some of them have been described in 
different published papers and videos. We detail below the technical aspects of the different proce-
dures, starting with the total gastrectomy full-laparoscopic approach (LTG) for cancer.65–67 
Figure 3: Trocar position for laparoscopic total gasterctomy.
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It is accomplished with ports as figure 3 shows. Duodenal section is made 2 cm distal to pylorus 
with a 60mm Echelon ® Flex 1.5 mm staple (blue cartridge) without over sewing the staple line, 
unless intraoperative active bleeding is seen. After proceeding with the anatomical dissection and D2 
lymphadenectomy, the esophageal section is made 2 cm below the cardias with a 60mm Echelon ® 
Flex 1.5 mm staple (blue cartridge) (figure 4). 
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Figure 4: Schematic representation and laparoscopic view of esophageal section in laparoscopic total 
gastrectomy. 1: Right paracardial lymph nodes 2: Left paracardial lymph nodes 3: Lesser curvature lymph nodes 
7: Left gastric artery lymph nodes 8: Common hepatic artery lymph nodes 9: Celiac artery lymph nodes
material and methods
19
Figure 5: Design of gastroyeyunal anastomosis performed with barbed suture. A: posterior plane B: anterior plan
A B
Manual intracorporeal EJA is made with barbed suture. Starting the posterior layer in the left of 
the esophageal staple line, it is achieved by a locking suture of a 15cm V-Loc® (Covidien, United 
Kingdom). Taking the esophageal staple line early in the suture a full-thickness stitch both in jejunum 
and esophagus is done (figure 5). When the suture is completed, the wire is cut without a knot, 
with a tail of 1.5 cm. An optional reinforcement of this layer can de made with simple reabsorbable 
stitches, to optimize and bind the protuberant intestinal mucosa. Anterior layer starts from the left at 
the first stitch of the posterior suture and fixes the jejunum to the esophagus with large extramucosal 
stitches. Suture ends beyond the end of the posterior suture and the wire is then cut without a knot 
with a tail of 1.5 cm. Check of sealing is made optionally.
Fifty centimeters below EJA, Roux-en-Y mechanical side-to-side JJA is made with a 60mm Echelon ® 
Flex 1.5 mm staple (blue cartridge). Defect for introduction of the stapler is closed indistinctly manually, 
with a barbed suture or mechanical. Afterwards the alimentary limb is fixed to the left diaphragmatic pillar.
Non-aspirative drain is left systematically under posterior face of EJA. Specimen is removed by a 
Pfannenstiel incision. Both naso-gastric tube and epidural analgesic are placed if necessary. ICU 
surveillance is made during the first 24-48 hours. A negative transit made systematically on the 5th 
postoperative day (POD) and if there is no evidence of leak or obstruction, oral intake is started.
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Figure 6: Schema of laparoscopic subtotal gastectomy. 
A: gastric section B: completion of anterior plane of gastro-yeyunal anastomosis with barbed suture.
1: Right paracardial lymph nodes 2: Left paracardial lymph nodes 7: Left gastric artery lymph nodes 8: Common hepatic artery 
lymph nodes 9: Celiac artery lymph nodes
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For subtotal gastrectomy full laparoscopic approach (LSTG) (figure 6) gastric section is made 
with automatic devices (60mm Echelon ® Flex 1.5 mm staple -blue cartridge-) in the union of the 
proximal fifth with the distal four fifths. Staple line is over-sewed with a barbed suture (V-loc®). Manual 
end-to-side GJA is made with a barbed suture and also can be reinforced in the posterior face with 
vycril stitches. Roux-en-Y JJA, drains, naso-gastric tube, epidural analgesic and ICU surveillance is 
made as explained before. Oral intake is started the 3rd POD if there are no postoperative problems.
Figure 7: Trocar position for laparoscopic gastric bypass. A: inframesocolic step B: supramesocolic step.
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Preoperatory endoscopy was performed in all patients with benign disease or morbid obesity under-
going surgery. Our group performs Roux-en-Y laparoscopic gastric bypass 68,69 retro-gastric 
and transmesocolic (figures 7, 8). A 2.8 cm mechanical (Echelon ® Flex 60 mm 1.5 mm cartridge) 
side-to-side isoperistaltic GJA is made closing the orifice with a barbed suture (V-loc®). Roux-en-Y 
JJA is made as described before. Naso-gastric tube and drain guarding GJA are selectively placed. 
Figure 8: Gastric bypass carried out by our group: retrogastric and transmesocolic.
For laparoscopic Sleeve Gastrectomy (LSG) 70 (figure 9) the gastroepiploic ligament section is 
made from 7 cm proximal to the pylorus until Hiss angle with an ultrasonic device (Harmonic Ace®). 
A 32 Fr Faucher tube calibrates and mechanical section (Echelon ® Flex 60 mm) is made; the first 
two cartridges are 1.8mm and the others are 1.5mm. Staple line is over sewed with a barbed suture 
(V-loc®) if necessary (e.g. bleeding); naso-gastric tube and drains similarly. Morbid obese patients 
with OSA are monitorized in ICU during at least 24 hours.
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Figure 9: Trocar position and representation of laparoscopic sleeve gastrectomy.
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Postoperative care is standardized in all patients and includes subcutaneous low molecular weight 
heparin and proton pump inhibitors for the first postoperative month. No routinely radiological series 
after bariatric surgery are performed; as opposed to the systematically upper gastrointestinal series 
(UGS) with water-soluble contrast swallow who are done on the 5th POD systematically after LTG. 
If the contrast passed through the bowel and there was no evidence of leak or obstruction, the 
patients’ diet was advanced. The patients after bariatric surgery were discharged on postoperative 
day 3 or 4 while after surgery for cancer was on 7th to 10th POD. Drainage was removed (when 
present) on postoperative days 4-8.
2.4. DIAGNOSIS 
Upper gastrointestinal series (UGS) with water-soluble contrast swallow are done on the 5th POD 
systematically after LTG. In contrast to previous, after bariatric surgery, necessity of diagnostic exams 
is determined by clinical symptoms and/or exploration.71 In hemodynamic stable patients with 
tachycardia, nausea, vomiting or abnormal postoperative evolution with or without abdominal pain a 
CT scan with oral and intravenous contrast is made. Nowadays the first diagnosis tool used in these 
cases, when possible, is an endoscopic exploration. The location, size (expressed in percentage of 
circumference) and perfusion of the anastomosis are verified. If necessary, an endoscopic treatment 
would be performed.
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Exploratory laparoscopy or laparotomy is the diagnostic method in hemodynamic unstable patients, 
that allows at the same time treatment. Optimizing treatment in ICU is done whenever possible.
2.5. CONSERVATIVE MANAGEMENT
Conservative treatment consists of broad-spectrum antibiotics, nutritional support 
and effective drain of collections (US or CT-guided). Oral feeding is started afterwards. 
CT scan with oral contrast evaluates leak closure and withdrawal of the drain 7-10 days after treat-
ment instauration. 
2.6. SURGICAL MANAGEMENT
When surgery was needed reoperation was done by laparoscopy, if possible, or laparotomy. Anas-
tomosis is verified looking for complete dehiscence and transmural necrosis. When urgent reinter-
vention is necessary, in absence of previous signs, peritoneal washout, aspiration and effective drain 
placement around anastomosis is done. Rarely reinforcement stitches in the anastomosis can be 
made, due to the inflammation process. If there is a complete dehiscence reconstruction or diversion 
of the GI tract are considered.
Commonly late postoperative leaks allow elective surgery once the inflammation process is under 
control, granting a reconstruction of the anastomosis in safety conditions.
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2.7. ENDOSCOPICAL TREATMENT
Figure 10 : Deployement of stent under fluoroscopy in an EJ anastomotic leak.
Patients who submitted endoscopic exploration and had no transmural necrosis and a less than 
70% of the circumference anastomosis defect are candidates for stent. In our center SEMS covered 
(Ultraflex®, Boston Scientific, USA) were deployed under endoscopy or fluoroscopy (figure 10). 
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An UGI transit with oral contrast is made after 24 hours and if leak is sealed oral intake is started, 
progressing to a diet as patients without leak if there is a good tolerance (figure 11). At this point 
patients are discharged. During this period if there is abdominal pain or dysphagia a CT scan or transit 
is made to verify the stent position.
Figure 11: SEMS covered (Ultraflex®, Boston Scientific, USA) is deployed under fluoroscopy in an EJAL. 
Transit with oral contrast made after 24 hours shows leak sealed. Oral taken is started afterwards.
Stents are left in place (if well tolerated) 6 weeks. A transit with oral contrast is made before with-
drawal to ensure leak closure. 
2.8. LITERATURE SEARCH
Literature review was performed in electronic data bases Pub Med, Up to Date, Clinical Key, Cochrane 
and also in Google Academic using a combination of keywords: “morbid obesity”; “gastric cancer”; 
“laparoscopy”; “laparoscopic Roux-en-Y gastric bypass”; “laparoscopic sleeve gastrectomy”; “gastrec-
tomy”; “complications”; “anastomotic leak”; “risk factors”; “outcomes”; “morbidity”; “mortality”; “reoper-
ation”; “sepsis”; “endoscopy”; “stent”; “repositionable”; “self-expandable metallic stent”; “Clavien-Dindo 
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classification”; “enteral nutrition”; “nasointestinal tube”; “length of stay”. Boolean operators (NOT, AND, OR) 
were used, when appropriate, to widen or narrow the search. A selection of the potential relevant articles 
was done after reading the abstracts; this assortment was completely reviewed. No meta-analysis was 
carried out to combine the results of the different studies, due to global heterogeneity.
2.9. STATISTICAL ANALYSIS
We presented continuous data as mean and standard deviation or median and interquartile range 
(IQR) or extreme values. When comparing two groups, we used the Student t test for normally 
distributed data; otherwise, the nonparametric Mann-Whitney U test was used. For proportions, we 
used the Pearson χ2 test or the Fisher exact test for scarce data. We evaluated assumptions for all 
statistical models and found none were violated. We considered P < .05 as statistically significant; 
all statistical tests were 2-sided. We used IBM SPSS Statistics software package version 14.0 (IBM 
España S.A., Madrid) for statistical analysis.
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Between January 2003 and April 2013 1,856 patients underwent a supramesocolic laparoscopy 
surgery in Centre Hospitalier of Luxembourg: 121 gastrectomies for cancer (LTG: 58 and LSTG: 63); 
1654 LGBP; and 81 LSG. Postoperative leak was diagnosed in 15(0.8%) patients (figure 12). Table 5 
 summarizes patients diagnosed and treated in our center.
Patient Gender Age BMI (kg/m2)
Surgical 
Procedure IAAL location 
Time of 
appearance
1 M 74 26 LTG EJA A
2 M 73 29 LTG EJA A
3 M 72 22 LTG Duodenal stump A
4 M 48 24 Roux-en-Y Antrectomy GJA C
5 F 29 41 LSG Hiss angle A
6 F 27 40 LSG Superior third staple line C
7 M 23 40 LSG Hiss angle C
8 F 31 43 LGBP GJA A
9 F 61 40 LGBP GJA A
10 F 48 42 LGBP GJA A
11 F 37 42 LGBP GJA A
12 F 25 39 LGBP GJA A
13 M 30 42 LGBP Hiss angle C
14 M 41 50 LGBP GJA - Gastric remnant A
15 F 51 53 LGBP JJA C
Table 5: Patients diagnosed of IAAL after an UGI surgery at Centre Hospitalier of Luxembourg.
(M: male - F: female - A: acute - C: chronic)
IAAL ≈ 1% (15)
(1841) 99% ≈ NO IAAL
100
50
150
1650
117
3 3 18
1646
78
Gastrectomy for cancer
LGBP
LSG
Others
NO IAAL IAAL
Figure 12: Representation of IAAL rate (0.8%) after upper GI surgery in CHL. 
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3.1. EPIDEMIOLOGICAL CHARACTERISTICS
NO LEAK (99.2%)
N=1841
LEAK (0.8%)
N=15
Malign process 117 3
Benign process 1724 12
Gender
Female 1112 (60.4%) 8 (53.3%)
Male 729 (39.6%) 7 (46.7%)
Age (years) median (range)
Malign process 67 (36-82) 73 (72-74)
Benign process 39 (13-68) 37.5 (23-61)
BMI (kg/m2) median (range)
Malign process 26 (21-32) 25.6 (22-29)
Benign process 49 (39-70) 41.3 (24-53)
Death (leak related) 1 1
Table 6: Epidemiological characteristics
Table 6 shows the epidemiological characteristics of all patients. In the group of patients with leaks, 8 
(53.3%) were women. The median age and BMI in oncologic patients was 73 years (72-74) and 25.6 kg/m2 
(22-29). In patients with a benign process median age was 37.5 years (23-61) and mean BMI 41.3 kg/m2 
(24-53); differences were not statistically significant probably because of our small sample size.
Figure 13: Associated comorbities in 15 patients with IAAL.
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Most of the patients who developed leaks had multiple associated comorbidities (figure 13), including 
hypertension (6), type 2 Diabetes Mellitus (7) and malnutrition (5). There were 4 with gastric cancer 
diagnosis, of whom 3 underwent neoadjuvant treatment. All of them presented preoperative proteins 
under normal levels. The differences between patients who developed leak or not are vitally important, 
but are not the prime concern in this particular study. 
LGBP
8
LTG
3
1
LSG
3
ANTRECTOMY
Figure 14: Previous surgery in patients diagnosed of IAAL. 
Previous surgery (figure 14) in 8 (53.3%) patients was a LGBP, a LTG in 3 (20%), a LSG in 3 (20%) and 
in 1 (6.7%) open antrectomy with Roux-en Y reconstruction. First surgical procedure was performed 
in our center in 10 (66.7%) patients. Negative margins were achieved in 100% of the patients with 
a malign process.
3.2. CLINICAL AND DIAGNOSTIC CHARACTERISTICS
In our study there were no asymptomatic patients when diagnosis was achieved. Frequent clinical 
manifestations were (figure 15): abdominal pain (13), tachycardia (11), tachypnea (10) (figure 16) and 
fever (6). The initial clinical status was in 5 patients mild sepsis, severe sepsis in 5, and septic shock in 
2, being the only death of our series among this last group. Only 3 patients did not have SIRS criteria. 
During early postoperative, the presence of tachycardia with the absence of fever were important signs 
to exclude IAAL. In the same manner, discharge or change of secretion through the abdominal drain 
gave rise to the suspicion of leak (figure 17): sero-hematic to purulent (5), intestinal (4), gastric (3), 
biliary (2) or saliva (2).
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Figure 15: Clinical manifestations in patients diagnosed of IAAL.
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Figure 17: Suspicion of leak can be made 
also when a discharge or change of secretion 
through the abdominal drain occurs.
Figure 16: Initial clinical status of septic shock 
was presented in 2 patient, one them deceased.
Table 7 shows the differences with regard to epidemiologic characteristics, symptoms and labora-
tory results between patients who underwent conservative or surgical treatment. Those who were 
diagnosed and operated afterwards had an increased presence of fever, tachycardia and tachypnea 
than patients who underwent conservative management ( p > 0.05). Also levels of WBC count, CRP 
and PCT were higher ( p > 0.05). Time of appearance after surgery and location of leak is shown too. 
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There were 10 patients diagnosed of acute IAAL and 5 cases of chronic leak. Seven patients devel-
oped anastomotic leaks at the GJA, one of them with an associated leak at the gastric remnant.
Clinical 
Characteristics
Total
(n=15)
Conservative 
management
(n=3)
Surgical  
management
(n=12)
Age (years) median (SD) 44.6 (18.1) 44 (19.3) 44.8 (18.7)
BMI (kg/m2) median (SD) 38.2 (9) 40.7 (1.2) 37.6 (10)
Gender (female/male) 8F/7M 2F/1M 6F/6M
Fever (>38ºC) 6 1 5
Abdominal pain (VAS >6) 13 3 10
Tachycardia (>90 bpm) 11 2 9
Tachypnea (>20 bpm) 10 2 8
WBC count (mm3) mean (SD) 16,533 (2,875) 16,000 (1,732) 16,666 (3,143)
CRP (mg/dL) mean (SD) 162 (73.1) 133.3 (76.4) 169.2 (21.3)
PCT (g/L) mean (SD) 3.8 (2.2) 2.3 (1.5) 4.3 (2.2)
NO SIRS 3 1 2
Mild sepsis 5 1 4
Severe sepsis 5 1 4
Septic Shock 2 0 2
Time of appearance
Acute IAAL 10 2 8
Chronic IAAL 5 1 4
IAAL location
EJA 2 0 2
GJA 7 2 5
JJA 1 0 1
LSG stapler line 4 1 3
Duodenal stump stapler line 1 0 1
Table 7: Clinical characteristics, laboratory levels, time and location of IAAL in 15 patients with conservative or 
surgical management.
Figure 18: CT scan with oral and intravenous contrast showing IAAL findings: extravasation of contrast material 
through the anastomosis or a staple line, adjacent collection, free intra-abdominal liquid, pleural effusion and free 
intra-abdominal gas.
results
36
Figure 19: Transit with oral contrast can show-up chronic leaks with scarce clinical impact as well as they provide 
information about esophageal and gastric emptying.
IAAL diagnosis (Table 8) was achieved with a CT scan with oral contrast (figure 18) in 13 (86.7%) 
patients. Dehiscence was assessed by endoscopy in 9 (60%) patients, even before undergoing 
surgery in 5 of them, showing a leak in 7 patients and ischemic injury plus leak in 1 case. An anas-
tomotic ulcer was described in 1 patient. Two (13.3%) patients were submitted to urgent exploratory 
laparoscopy because hemodynamic instability at diagnosis.
Anatomical IAAL 
Location
Clinical 
criteria
CT scan with 
oral contrast
CT scan+ 
preoperative 
endoscopy
EJA 0 2 0
GJA 1 4 2
JJA 0 1 0
LSG stapler line 0 1 3
Duodenal stump stapler line 1 0 0
Table 8: Diagnostic methods of IAAL.
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3.3. MANAGEMENT DATA 
MANAGEMENT 
n=15
INMEDIATE SURGERY
n=7
NO INMEDIATE SURGERY
n=8
Figure 20 : Patients’ management resumed flowchart. 
Due to patients’ clinical status, radiological findings, leak localization and time of diagnosis of leak an 
immediate surgery was achieved in 7 patients. In the other 8, less invasive complementary exams 
were possible to perform (endoscopy, CT/US draining). Among these, conservatory management 
was applied in 4 of them.
3.3.1. SURGICAL MANAGEMENT
Figure 20: Characteristics of interventions in surgical management. 
A: Urgent procedures were more common in surgical managment. 
B: Number of reinterventions per patient treated with surgical management.
Urgent
55.5%
Elective
44.5%
A
None
2
One
6
Two
5
> Three
2
B
Surgical treatment was finally carried out in 11 (80%) patients. Figure 15 show that reoperation was more 
frequently immediate and done once (40%). Laparoscopic approach was the most used (80%). 
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STOP 
n=2
EJALª GJALª GJALªGJALª JJAL stumpª
LAPAROSCOPY
(Stent Migration)
HEALING
n=3
NO HEALING
n=1
ELECTIVE 
SURGERY
ELECTIVE 
SURGERY
STOP EXITUS
LAPAROTOMY 
n=1
IMMEDIATE 
SURGERY 
n=7
ENDOSCOPY
+ STENT 
n=4
NO  
ENDOSCOPY 
n=2
LAPAROSCOPY 
(Lavage + Drain)
n=6
Figure 21 : Flowchart of patients who have undergone immediate surgery. a acute 
Surgery was performed immediately in 7 patients (figure 21): 
• 1 urgent laparotomy in a patient with an acute GJAL after LGBP. 
Patient died with a laparostomy after 2 days in ICU. 
• 6 laparoscopies for peritoneal washout and effective drain placement.  
After intraoperatory findings, 2 patients were not candidates for endoscopical exploration: 
◀	 An acute leak in the staple line of duodenal stump, that did not require further invasive 
treatments.
◀	 An acute JJAL that afterwards needed an elective surgery for resection and redo of JJ 
anastomosis (figure 22). 
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Figure 22 : A and B: Radiological findings of a JJAL with abscess in abdominal wall. C: Specimen of JJA anasto-
mosis with leak orifice indicated with catheter.
A B
C
Post-operative endoscopy and stent deployment was achieved in the other 4 patients (figure 23). 
Healing of the leak was completed in 3 cases: 2 acute EJAL and 1 acute GJAL (which needed 
re-operation by laparoscopy due to stent migration). Sealing was not achieved after stent positioning 
in 1 patient, an acute GJAL after a LGBP, who required another 2 re-operations (1 laparotomy and 
1 thoraco-phrenic laparotomy).
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D
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C
A
Figure 23 : A: CT scan showing an acute EJAL. B,C: Stent deployement and radiological control. D,E: Leak 
sealed after stent retrieval and transit with oral contrast without extravasation.
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STOP STOP
ELECTIVE 
SURGERY 
(open TG)
NO  
HEALING 
n=1
HEALING 
n=1
CT OR US DRAIN 
n=2
ELECTIVE 
SURGERY
NO 
STENT 
n=1
STENT 
n=4
STOP 
n=1
STOP 
n=1
ELECTIVE 
SURGERY 
n=2
+Vicryl plug 
±FS
HEALING?
Need effective drain?
LAPAROSCOPY  
+ DRAIN 
n=2
NO 
n=2
ENDOSCOPY 
n=5
ELECTIVE 
SURGERY 
n=1
NO  
IMMEDIATE 
SURGERY 
n=8
LAPAROSCOPY  
+ DRAIN
Gastric 
Remnant
GJAL GJALª HissHiss
SG + 
Stricture
Hiss, 
GJAL
Figure 24: Flowchart of patients with no-immediate surgery. Shaded area represents those who finally required 
surgical management. FS: fibrin sealants.
Due to clinical status and/or radiological findings 8 patients did not go immediate surgery (figure 24), 
allowing other exams to accurate their management and therefore, selecting patients candidates to 
conservative management (4).
A chronic leak from GJA to the gastric remnant, well tolerated, was candidate to elective surgery 
once the inflammatory process had been treated with antibiotics. A laparoscopic fistulectomy was 
performed and patient was discharged (figure 25). 
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Figure 25: Chronic IAAL in Hiss angle after LSG. Healing was not carried out and an elective open total gastrectomy 
was performed.
A B
C D
Endoscopy was performed in 5 patients recognizing patients for either surgical (3) or conservative (2) 
treatment due to IAAL characteristics:
• Stent positioning followed by urgent laparoscopy for effective drain placement was achieved in 
2 patients with chronic IAAL after LSG (Hiss angle and upper third of staple line). In these cases, 
healing was not carried out and elective surgery was needed performing an open TG and a 
laparoscopic side-to-side GJ bypass (figure 26) covering a large defect respectively. In this last 
case, as intraoperative finding, a stricture of the sleeve was associated.
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Figure 26 : Leak in upper third of staple line of LSG.
A: Initial conservative management with stent.
B: Transit with oral contrast after stent withdrawal showing a chronic leak.
C: Schematic drawing of the laparoscopic side-to-side GJ bypass performed.
D: Transit with oral contrast checking lateral GJ bypass.
120 cm
40 cm
A
B
C D
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• A chronic GJAL with an entero-cutaneous fistula after a Roux-en-Y antrectomy (figure 27) trans-
ferred from another center was not candidate for stent placement. After intravenous antibiotics, 
elective surgery was accomplished doing a laparoscopic Roux-en-Y degastro-gastrectomy. 
Insufficient gastric resection after a duodenal ulcer was found out to be the reason of this leak. 
No procedure-related morbidity was observed in these patients where endoscopy was finally 
performed pre-operatory.
Figure 27 : A: Chronic GJAL with enterocutaneous fistule appears in CT scan with oral contrast. B: While definitive 
laparoscopic surgery, insufficient gastric resection after a duodenal ulcer was found out to be the reason for the leak.
A
B
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3.3.2. CONSERVATIVE MANAGEMENT
STOP STOP
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n=4
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n=1
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n=1
ELECTIVE 
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+ DRAIN 
n=2
NO 
n=2
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SURGERY 
n=1
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Figure 28 : Shaded area of flowchart highlights conservative management. a acute.
There were 4 patients, all of them with benign pathology, who underwent conservative management. 
They were hemodynamically stable and presented radiological findings like localized abscess and/
or minimal perianastomotic oral contrast extravasation (if this liquid collection was more than 3 cm a 
percutaneous drain was placed). All of them were chronic IAAL, 2 in a GJA after LGBP and 2 in the 
staple line after LSG, next to GEJ.
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In figure 28 non-operative treatment is summarized. An effective percutaneous drain was required 
in 2 patients. In one case drain was effective and after 21 days, it was removed and patient was 
discharged. In only one case percutneous drain was not effective and patient has been managed 
surgically. It was a chronic IAAL in Hiss angle after a LGBP. A laparoscopy for effective drainage and 
peritoneal washout allowed optimal conditions to perform later an elective open total gastrectomy. 
Other 2 patients underwent digestive endoscopy and stent was deployed. Treatment was completed 
with a percutaneous drain in 2 of them. The other patient suffered disphagia and stent was with-
drawn. Treatment continued with endoscopic clips and fibrin sealants, without results. It is why 2 
vicryl plugs were placed (figure 29) with 7 days delay between both of them. No leaks were seen in 
radiology series and healing was confirmed 4 weeks later.
Figure 29: Other endoscopical treatments must be considered if there is no sealing with stent. Vicryl plug can 
achieve it.
Complications after conservative management are summarized in table 9 further on. Conservative 
management healed leak completely in 3 out of 4 patients. Mortality rate was 0 in this group.
3.3.3. ENDOSCOPICAL TREATMENT
To summarize 8 SEMs were successfully placed in all patients. Mean healing time (time to stent 
retrieval) was 6 weeks. Leak occlusion was obtained in 5 patients (healing rate: 62.5%). Supplemen-
tary endoscopical treatments were used in 3 patients: clips and fibrin sealants carried trough healing 
in 2, and in the third case FS did not work; a vicryl plug was placed twice (with 7 days of difference) 
verifying sealing 7 days after. 
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Only 1 patient presented dysphagia; it was easily treated by stent removal. Migration of the stent 
was observed in 2 patients (migration rate: 25%). One stent was removed by flexible endoscopy and 
replaced; the other case developed bowel obstruction because of migration into the small intestine 
(figure 30) with subsequent failure to pass the stent through the rectum. The patient required an urgent 
laparoscopic reintervention for removal. No patients developed a stricture on the anastomosis.
Figure 30 : Migration is an important drawback of stents, specially if it reaches small bowel. If withdrawal is not 
possible with endoscopy, laparoscopic retrieval is needed, accomplishing an enterotomy.
3.3.4. COMPLICATIONS 
Grade I
2
Grade II
3
Grade III
7
Grade IV
6
Grade V
1
Figure 31: Complications in 15 patients with IAAL according to Clavien-Dindo classification.
Complication rates and a comparison between patients who underwent conservative versus surgical 
treatment are summarized in figure 31 and table 9. The most frequent complications (38.8%) were 
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those that required surgical, endoscopical or radiological intervention (Clavien-Dindo III). Life-threat-
ening complications requiring ICU management (Clavien-Dindo IV) were 33.3%. These major compli-
cations (ARDS, MOF,) were more common in patients who underwent surgical treatment (5) versus 
conservative treatment (1) ( p > 0.05).
Characteristics Total  
(n=15)
Non-Operative 
(n=3)
Operative 
(n=12)
Transfer from other centers 5 1 4
Readmission 8 3 5
Median length of ICU stay  
after treatment in days (SD) 12.8 (19.5) 10 13.1 (20.7)
Median length of hospital stay  
after diagnosis in days (SD) 21.5 (23.5) 15 (6.5) 23.1 (26.2)
Median length of global 
hospital stay in days (SD) 23.7 (23.5) 15 (6.5) 26.1 (26.2)
Complications
Grade Clavien-Dindo I 2 (11.1%) 1 1 wound infection
Grade Clavien-Dindo II 3 (16.6%) 1 2 UTI
Grade Clavien-Dindo III 7 (38.8%)
 IIIa 1 disphagia 4 tracheotomy, eschar, IAA, pleural effusion
 IIIb 2 
Grade Clavien-Dindo IV 6 (33.3%)
 IVa 1 RF 3 ARDS, DIC
 IVb 2 MOF
Mortality n (%) 1 (6.6%) 1
Table 9: Comparison of hospitalization and operative complications between patients with IAAL managed 
conservative versus surgical. UTI: urinary tract infection - IAA: intraabdominal abscess - RF: renal failure 
ARDS: acute respiratory syndrome - DIC: disseminated intravascular coagulation - MOF: multiorganic failure
It is to be noted that in non-operative management group a minor complication due to stent 
(dysphagia) was present in 1 patient. Only 1 patient developed a major complication (renal failure) 
that required ICU admission. 
On the other hand, in the surgical management group, 5 major complications were registered. Four 
patients developed various combinations of respiratory, congestive and renal failure, and intraab-
dominal abscess or eschars with different degrees of severity. Patients with conservative manage-
ment had short intensive care course (mean: 10 days versus 13 days) and hospital stay (mean: 15 days 
versus 26 days). Statistical analysis by subgroups revealed that male gender with malignancy had longer 
stay; there was no significance probably due to the small sample size. Mortality was not observed after 
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conservative treatment and/or stent insertion, whereas 1 patient died from septic complications and 
multiorganic failure after surgery (in-hospital mortality rate 0% versus 6.6%).
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Anastomotic leaks are a serious complication in patients undergoing UGI surgery for contributing signifi-
cantly to operative morbidity and mortality independent of underlying comorbidities.72 It also affects 
long-term survival, quality of life and prolongs hospital stay as well as increases costs of therapy.12,22 
In the setting of a leakage in an oncologic patient, growth of residual tumor cells may be affected by the 
increased magnitude and duration of inflammatory response 73 determining this event as an indepen-
dent predictive factor for overall survival. Also physical deterioration and a weakened immune system 
makes these patients no longer candidates for adjuvant treatment.12,73 Moreover patients with a IAAL 
have a higher incidence of wound infections, sepsis, thrombo-embolic events, internal hernias, small-
bowel obstruction, and respiratory and renal failure.26 Therefore IAAL management remains a challenge.
Considering that bariatric procedures are constantly increasing, we have to expect a rise in postop-
erative complications, anastomotic leakage among them. Besides the clinical impact this implies an 
increase cost of the treatment. Consequently nowadays we think it should be considered like a real 
public health problem. 
4.1. IAAL DEFINITION AND INCIDENCE
These days the most frequent UGI procedures holding an anastomosis and its potential complica-
tions are: subtotal and total gastrectomy, gastric bypass and sleeve gastrectomy. Considering that 
intratorathic anastomosis of esophageal surgery are localized in another cavity and may differ in their 
treatment, it has been excluded of this study. Therefore we propose defining intraabdominal anasto-
motic leak after UGI surgery as a defect of the intestinal wall at the anastomotic site (including suture 
and staple lines of section margins) of EJA, GJA, JJA and staple line leaks, leading to a communi-
cation between the intra- and extra-luminal compartments. As several authors suggested,74–78 they 
may be considered also peri-anastomotic abscess even if no communication can be proven with the 
intestinal lumen at the anastomosis. 
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Group Year Reconstruction n Leak (%)
Roder 79 1993 No specified 1654 7.2 - 12.7
Bonenkamp 80 1995 No specified 1078 9
Lang 40 2000 Roux-en-Y EJA 1114 7.5
Portanova 81 2010 Roux-en-Y EJA 173 5.2
Sah 20 2010 Multiple 1559 2
Sierzega 12 2010 Roux-en-Y EJA 690 5.9
Bracale 82 2010 Side-to-side 67 6
Yoo 73 2011 Roux-en-Y EJA 478 2.9
Lim 83 2012
Roux-en-Y EJA  
Billroth I and II
393 2.2
Migita 10 2012 Roux-en-Y EJA 327 5.8
Deguchi 27 2012 Roux-en-Y EJA 1640 2.1
CHL 2013 Multiple 121 3.3
Table 10: Incidence of gastrectomy for cancer leak.
Bearing in mind that IAAL definition after UGI surgery has not been considered yet in literature, 
comparing our IAAL rate with other studies is not possible, hence it will be compared by surgical 
procedures. Leakage rate in gastrectomy for cancer in our study was 3.3%. Compared to international 
series (table 10) our rate is among the lowest. Nevertheless it is important to note that leakage rate is 
independent of the type of reconstruction and surgical radicality.40 Leak rate after LGBP (table 11) in 
our group was 0.48%, also between the lowest. The incidence of LSG leaks (table 12) ranges between 
0 and 7%, since our 3.7% rate is among the lower incidence. It should be noted that this table includes 
series with super-obese patients (BMI>50 kg/m2) where leak rates are significantly higher. 
Group Year N Leak (%)
Higa 84 2000 1040 1
Marshall 85 2003 400 5.2
Podnos 86 2003
577
2497
1.73
1.98
Papasavas 87 2003 246 1.6
Dresel 88 2004 120 0.01
Fernández 89 2004 3000 3.2
Suter 91 2006 466 1.9
Durak 90 2008 1133 1.5
Maher 92 2008 450 2
Thodiyil 93 2008 2675 1.7
Ballesta 15 2008 1200 4.9
Csendes 50 2012 1764 3.4
CHL 2013 1654 0.48
Table 11: Incidence of LGBP anastomotic leak.
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Group Year N Leak (%)
Johnston 94 2003 100 1
Moon 95 2005 130 1
Cottam 96 2006 126 2
Lalor 97 2007 148 1
Lee 98 2007 216 1
Nocca 99 2007 163 6
Weiner 100 2007 120 3
Felberbauer 101 2007 126 0
Rubin 102 2008 120 0
Skrekas 103 2008 93 4
Burgos 104 2009 214 3
Fuks 105 2009 135 5
Menenakos 106 2009 261 4
Sanchez 107 2009 540 2
Casella 108 2009 200 3
Stroh 109 2009 144 7
Armstrong 110 2010 185 0
Csendes 111 2010 343 5
Lacy 112 2010 294 4
Ser 113 2010 118 3
Srinivasa 114 2010 253 2
Bellanger 115 2011 529 0
CHL 2013 81 3.7
Table 12: Incidence of LSG anastomotic leak.
After an exhaustive literature review we can conclude that a universally accepted definition of anas-
tomotic leakage of UGI surgery is needed, as well as common agreed standardized diagnostic algo-
rithms and uniform grading of severity. This may also contribute to have uniform criteria that would 
facilitate valid comparison of the results of different studies improving its management. 
4.2. DIAGNOSIS
Because epidural analgesia and laparoscopy diminish postoperatory pain, clinical signs and symptoms 
are mitigated; therefore a high index of suspicion should be maintained. We know there are patients 
with a higher risk to develop this complication and we have criteria to detect them. Also, identification 
of patients with severe sepsis or septic shock is carried out thanks to SIRS classification, an easy, 
effective, universal and low-cost method that can be performed bedside. Noteworthy is the absence of 
studies that correlates SIRS classification system with IAAL suspicion as well as the need of the diag-
nostic of the anastomosis’ morphologic characteristics. Early diagnosis of leakage will allow a prompt 
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and adequate management in a patient with no organ failure, but nevertheless radiological exams 
should not delay urgent surgery with the exception of a clinical context of pulmonary embolism.116 
Lamb et al 117 in 2004 conclude “that there is no role for routine contrast swallow after total gastrec-
tomy with a mechanical EJA, but patients with clinical suspicion of leakage should undergo urgent 
contrast radiology, plus endoscopy if the contrast examination is normal”. In bariatric surgery, 
a systematic esophagogram with oral contrast does not improve early diagnosis of leakage because 
of a high false negative rate (70%).28 The reason why, is that many leakages occur immediately after 
the exam is concluded. 28 The great value of this exam is when it is performed in patients with 
clinical suspicion, where it can achieve a sensitivity up to 92%.2 In addition, a CRP determination 
during 2 POD is a great value to predict postoperative complications, especially anastomotic leaks. 
Warschkow et al 118 propose that radiological exams could be restricted to those who present CPR 
levels above 229mg/l. It is to note that CRP can present elevated levels until 5th POD.119
Today thorax-abdominal CT scan with oral contrast and/or intravenous contrast can demonstrate 
extravasation of contrast material through the anastomosis or a staple line, an adjacent collection, 
free intra-abdominal liquid, oral contrast material residue in the drainage tube, pleural effusion and/or 
free intra-abdominal gas.120 But important limitations exist in its accuracy, in part because of issues 
inherent to the bariatric patient population that could make CT imaging impractical or impossible.121 
When UGI studies and CT are combined, up to one third of patients will have both studies interpreted 
as normal, despite the presence of a leak, so endoscopical or/and operative exploration 32 should be 
considered part of the diagnostic algorithm. It also may be borne in mind that surgical re-exploration 
that reveals no explanation for a post-operative patient’s worrisome clinical findings or deterioration 
should be considered an appropriate and indicated intervention and not a complication.121
Classically, endoscopy has been contraindicated in patients with anastomotic leak because it was 
thought that it could aggravate due to irritation and air insufflation. Page et al 122 valuated the safety 
and efficacy of endoscopy in diagnosing anastomotic leaks in 100 consecutive post-esophagectomy 
patients, all having reconstruction using the stomach. Endoscopy was performed within the first 
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week after operation. There was no evidence that the procedure caused damage to the anasto-
mosis or gastric conduit. Endoscopic exploration is a safe and highly accurate method of diagnosing 
leaks 45 providing unique information on the condition of the anastomosis allowing a more targeted 
approach to patient care in the context of anastomotic healing and in the treatment of leaks. To 
conclude, it is useful diagnosing leaks that are not seen in CT scan or esophagogram.23 
In our study there was no evidence post-operative that endoscopy caused damage to the anastomosis 
or gastric conduit. Seven (46%) patients who underwent pre-operatory endoscopy did not show differ-
ences in both reintervention or post-operative complications with respect to the others and…, and no 
further leaks developed subsequently, making endoscopy 100% accurate in the diagnosis of leaks after 
UGI procedures and providing useful information to plan a better surgical technique during re-operation. 
Thence until a few years ago in our center, when hemodinamically stable patients had torpid evolution 
or clinical suspicion a CT scan was performed; nowadays endoscopy is our first diagnostic method. 
4.3. TREATMENT
Treatment of IAAL has to be multidisciplinary, established promptly and determined by hemodynamic 
conditions of the patient and the characteristics of leakage to assure enteral nutrition as soon as 
possible. Enteral feeding started early during the treatment plays a significant role in leak closure.123
When proposing management, it is particularly important to considerate the severity, the location of the 
leak and the day of appearance. As Csendes et al 50 resume: in early leaks after surgery, with abdominal 
or pleural diffusion in CT scan and severe clinical and septic manifestations, localized in GJA or JJA, 
prompt surgical repair is needed. On the contrary, if leak appears several days after surgery, in the gastric 
remnant or in GJA, even if they have same CT scan findings, conservative management can be achieved. 
However, some authors stand that surgery remains the mainstay of treatment for leaks in bariatric proce-
dures.72 Ballesta et al 15 reported that 39% of patients with leak required surgery. Carucci et al 124 founded 
that 81% of patients required a revisional bariatric procedure. On the other hand, we must not forget that this 
procedure carries a higher complication rate because of added technical difficulty and patient comorbidity.72 
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4.3.1. SURGICAL MANAGEMENT
Hemodynamic unstable patients with severe sepsis, abdominal or pleural diffusion in CT scan need 
a prompt surgical repair.2,50 Laparoscopic approach is performed in our center when status of the 
patient allows it. Thus, the role for laparotomy remains anecdotal for hemodynamic unstable patients 
excluded of mini-invasive treatment, in order to diminish disadvantages and complications of opera-
tive treatment. Among these are included infection, dehiscence and eventration of the wound, compli-
cations originated from the alimentary jejunostomy and intraabdominal compartment syndrome.2
It is to mention the important role of laparoscopy, which provides a good evaluation of the status of the 
anastomosis (tissue perfusion, ischemia, size), consents a peritoneal lavage and positioning effective 
drains around the anastomosis. If needed, it also consents placing an alimentary jejunostomy. It is 
to be noted the particular benefit of this technique for leaks located in EG union, where placement 
of a percutaneous drain is particularly difficult. Reintervention has to be done very carefully avoiding 
tractions that can enlarge the defect. Primary repair in GJA, EJA and JJA is usually difficult due to the 
dense inflammatory infiltration and deep edema around the anastomosis.49,125–127 Thereby, except 
in the rare cases in which the defect can be easily identified and the tissue in the area is viable, 
primary repair should be referred.128 In these cases, wide drainage of the diaphragmatic space is the 
best option.85 Usually, within days, a reactive pleural effusion appears and systematic drains are not 
required.129 
Also patients who fail medical therapy or who may not be candidates for medical therapy alone may 
go on to experience the development of persistent leaks that will require surgical revision.72 Reoper-
ation in leaks after LSG should be the exception and not the rule.129 Recent studies (table 13) have 
demonstrated that non-operative treatment (percutaneous drainage, endoscopy, stent) is feasible, 
safe and effective; furthermore, it may avoid more mutilating procedures such as total gastrec-
tomy.108 In our study, 2 out of 3 LSG did not accomplish the goal with conservative treatment and 
underwent elective surgery. In one case, it was due to persistence of the fistula after stent, clips and 
fibrin sealants; an elective open TG was performed. In the other case, conservative treatment did 
not work out because leak was associated to stricture of the neo-gastric tube. In this case a lateral 
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bypass was achieved with a jejunum loop. Nevertheless, with stent placement, leak became chronic 
allowing definitive surgery when patient has been optimized clinically and nutritionally.
4.3.2. CONSERVATIVE MANAGEMENT
Hemodynamic stable patients, asymptomatic or with optimal clinical tolerance to leak (usually chronic 
IAAL) and no severe sepsis symptoms are candidates to multidisciplinary conservative management. 
The mainstay of this treatment is intravenous antibiotics, an effective drain and adequate nutritional 
support. To avoid additional morbidity and mortality associated with reoperation,61 several authors 
have described the use of endoscopically placed self-expandable stents in the management of 
post-operative leaks. Formerly results where published by surgical procedures however, as table 13 
shows, trend has changed and UGI post-operative leaks results are being published.
Once the effective drain (surgical or radiological) and optimization of general status of the patient are made, 
healing of the leak is achieved with a stent, which provides a physical barrier between the leak and the 
luminal contents, allowing the leak to heal while providing enteral nutrition, preventing parenteral nutrition 
disadvantages (cost, risk of vascular thrombosis and sepsis, less efficacy than enteral nutrition).2 Other 
advantages are, when necessary, that endoscopy enables collection drainage or placement of a naso-je-
junal tube.81,123 Stent can be placed when anastomosis has signs of good perfusion 45 and a circumfer-
ence defect is less than 70%.38,48,144 When possible, it can be deployed at the same time exploratory 
laparoscopy is performed, and whenever operative time and ICU resuscitation are not delayed.129 
Literature analysis revealed there is a lack of randomized controlled trials and that clinical success 
(table 13) of stent placement was achieved in almost 79% of reported patients with no differences 
between PSEMS and SEPS. The mean time of stent placement that was needed for healing was 5.3 
weeks and was not different between different stent types (range 3–10 weeks). Animal studies have 
suggested that 4 weeks should be sufficient for tissue healing.46 Based on the results of this study, 
however, it seems advisable to remove stents after a period of approximately 6 weeks because a 
shorter interval leads to incomplete leak closure and a longer interval may lead to stent migration or 
mucosal hypertrophy with increased difficulty of stent extraction or subsequent dysphagia.72
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Procedure Group Year Study Type n
Stent 
Type
Sealing 
Rate (%)
1st Attempt 
Success Rate 
(%)
Migration 
Rate (%)
Removal 
Time  
(Average)
Mortality 
Rate (%)
ESOPHAGUECTOMY
Doniec 41 2003
CR 
Retros 21 SEMS 81
Not 
reported 5 ? 5
Hünerbein 130 2004 CR 9 SEPS 88 Not reported 22 4w
Stent-0 
Surgery-20
Schubert 44 2005 CR 12 SEMS 92 100 16 2-8w
Not 
reported
Kauer 131 2008 CR 10 SEMS 70 Not reported 40 6w
Not 
reported
Dai 61 2009 CR 22 SEPS 91 41 23 6w 4.5
Schweigert 132 2011 CR 12 SEMS 83
Not 
reported
Not 
reported
Not 
reported 17
Freeman 133 2011 CR 17 SEMS/SEPS 94 18 82 17-9d
Not 
reported
BARIATRIC SURGERY
Salinas 52 2006 CR 17 SEMS 94 100 6 2-4m ?
Eisendrath 134 2007 CR 21 SEMS 81 62 5 Not reported
Not 
reported
Eubanks 135 2008 CR 13 SEMS/SEPS 85
Not 
reported 58 6w 0
Iqbal 136 2010 CR Retros 19
SEMS/
SEPS 85 46 47 4w 0
Begé 137 2011 P 22 SEMS Not reported 59
Not 
reported 0
Puli 72 2012 SReview 67 SEMS/SEPS 88
Not 
reported 17 13d-7m 0
Simon 138 2013 CR 9 SEMS 78 Not reported 0 6w
Not 
reported
UPPER GI SURGERY
Siersema 42 2003 CR Retros 11 SEMS 82
Not 
reported 9 7w
Not 
reported
Langer 43 2005 P 24 SEPS 92 Not reported 41
Not 
reported 25
Tuebergen 125 2008 CR 32 SEPS 78 50 6 46d (4-426) 15.6
Salminen 139 2009 CR 10 SEMS 80 70 10 5w 30
Leers 39 2009 CR 31 SEMS 92 84 3 6w Not reported
Blackmon 140 2010 P 23 SEMS 61 26 43 1m 16
Dai 143 2011 CR 41 SEPS/SEMS 86 7 35 23d 2.4
Feith 45 2011 CR 115 SEMS 70 Not reported 53 54d 9
Swinnen 47 2011 CR 88 SEMS 78 Not reported 14 8-10w
Not 
reported
D’Cunha 141 2011 CR 37 SEMS/SEPS 60 16
Not 
reported 33d 18.1
van Boeckel 38 2011 SReview 267 SEMS/SEPS 85
Not 
reported 12 -31 7w 13
van Boeckel 46 2012 CR 52 SEMS/SEPS 76 99 19 25d 2
Donatelli 123 2013 CR 15 SEMS 93 Not reported 33 28-73d
Not 
reported
Yimcharoen 142 2013 CR 18 SEMS/SEPS 72
Not 
reported 22
Not 
reported 11
CHL 2013 CR 8 SEMS 62.5 8 25 6w 0
Table 13: Quantitative analysis of literature review with all available studies on stent theraphy that compromised 10 
or more patients with esophageal anastomotic leakage after esophaguectomy, bariatric surgery or UGI surgery.
CR: Case Report - Retros: Retrospective - P: Prospective - SReview: Systematic Review.
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With regard to our study, our number of patients treated with stent is low, but it is to remark that 
our global leak rate is very low. Like most of the other series, this study is a retrospective cohort 
and SEMS are placed. Our success rate (62.5%) is below the average rate but this is influenced by 
our small sample size. The majority of leaks managed with stent resolved on the first attempt. Time 
stent was placed (6 weeks), was among the average rate of the studies (5.7 weeks (range 3.5-10)). 
The main drawbacks are stent migration and tissue in or over-growth. Complication rate due to 
stents varies between 23-29% in the main series; rates are higher treating EGJ anastomotic leaks.123 
Minor complications include transient dysphagia/nausea/vomiting, dysphagia caused by severe 
hyperplasia, distal ulcers and rupture of coating in SEMS. They can be easily treated by SEMS 
removal, balloon dilation or SEPS insertion.47 Major complications (bleeding, tracheal compression 
and perforation) are rare and are related to specific conditions such as an anastomotic leak with tight 
angling.47 Strictures in the place of mucosal hyperplasia are the main long-term complication after 
SEMS removal. It can be treated with balloon dilation.47,145 
The high migration rate is likely related to the design of the stents rather than the endoscopist’s 
technique.72 It is also significally lower in nititol stents, superposed stents, polyester stents larger 
than 15 cm and nititol stents larger than 12cm.136 Several authors have made different proposals 
to diminish this complication. Suggestions like increasing the number of anchoring components,146 
using two stents with more than 3 cm of superposition,140 modifying the proximal part of a partially 
covered stent with two threads of polypropylene that will be exteriorized and fixed,147 or deploying 
an uncovered stent inside a covered stent have been proposed.148 Slightly stiffer, less compliant and 
longer stents have also been suggested for reducing migration.136 
On the other hand, stricture due to mucosal hypertrophy is a less common occurrence. No hyper-
plasic strictures were reported in our series. Incidence is not well described in literature and it is 
usually during the first two months after stent placement but also at a later stage.149 Van Boeckel 
et al 38 in a systematic review found that tissue overgrowth was higher with PSEMS (12%) 
compared with SEPS (3%) and FSEMS (7%) (p = 0.68) although this result was not significant. 
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Moreover, tissue in- and/or overgrowth may complicate removal of PSEMS in patients, resulting 
in a second esophageal perforation.150 Hirdes et al 151 describe a technique to remove embedded 
PSEMS placing a fully covered stent of the same diameter inside the FSEMS. This so-called stent-
in-stent method causes necrosis of the hyperplasic tissue. In their experience, both stents can be 
removed uneventfully after a period of 7–14 days. 
Complication rate of SEMS versus reoperation is lower and reduces healing time, hence recovery time, 
morbi-mortality rates and avoids other aggressive and expensive procedures.20,45,48,61,123,125,130,140 
Successful stent removal after leak sealing was 75% in our study. Among reasons for failed endo-
scopic extraction are stent migration and mucosal hypertrophy. In our study 2 cases (25%) of migra-
tion were reported, only 1 underwent surgery for stent extraction; migration rate in literature is 22.5% 
(range 9-53). Our intrahospitalary mortality rate due to endoscopic procedures was 0 while in the 
literature review mean was 7% (ranges 2-50%). It may well compare favorably with mortality rate 
after surgical management, 6.6% in our series.
It is to be noted that other mini-invasive endoscopical treatments, such as clips, fibrin sealants 
(FS) and vicryl plugs, were used providing leak sealing in 33.3% of the cases. FS have been 
widely used in surgery and there is a long experience. Literature confirms its efficacy, demon-
strates local tolerance and the absence of undesirable effects and contraindications but very little 
is published about the use of FS in early treatment of GJ leaks. Small wall defects would specially 
benefit from them.152–155 
Nowadays the use of FS is reported in cases or small series.32,152,156 Brolin et al 54 reported 3 patients 
with IAAL after LGBP who received FS, 2 of these closed after one treatment only. The mean length 
of stay was 33 days. This group concluded that FS provides safe and successful treatment of patients 
who develop gastric leaks after bariatric operations. Böhm et al 156 have proposed a treatment algo-
rithm combining FS and vycril mesh. They reported 39 cases of anastomotic leaks after surgery for 
UGI cancers that were treated with FS alone (n=24) or with combination of Vicryl plug and FS (n=15), 
showing complete healing after one to four sessions in 13 of the 15 patients (87%) who underwent 
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vycril/FS treatment. There is also an anecdotic case report of n-butil-2-cyanocrylate (Hystoacryl®) 
via submucosal injection into the lateral walls of the fistula rather than injection into the fistula.157 
The glue is injected into the submucosa until the lumen is occluded, ensuring that the fibrin plug does 
not become dislodged. No abrasion or depithelialization of the fistula tract is required. Also Kumar et 
al 158 have recently published novel endoscopic therapies that have demonstrated safety, such as a 
mushroom shaped metallic stent, nitinol clips or a vacuum assisted sponge closure (VAC) therapy. They 
conclude that these devices are steadily building evidence for efficacy relative to surgical management.
In conclusion, protocols for endoscopic treatment (retrieval, replacement, association of a concomi-
tant treatment) are needed, as well as randomized trials to compare different stent types and the ideal 
stent design. However, due to the limited number of patients, this is unlikely to occur.38 Research 
is conducted to biodegradable formulations to cover ruptures or anastomotic leaks.38 This material 
has been shown to stimulate connective tissue and vascular ingrowths and displays only minor 
hyperplasic tissue formation.159
4.4. PREVENTION
Multiple preventive actions can be applied. As other authors, our team believes that these proce-
dures should be performed in an experienced and accredited center after preoperatory selection 
and optimization of patients. Although there is no clear explanation for such a finding, this may be 
correlated with overall cardio-circulatory function and its influence on the blood supply and tissue 
oxygenation at the anastomotic site.12 In oncologic resections, the nutritional status and cachexia 
of the patient are so important for success. In this cases, our group has experience placing, radio-
guided or via endoscopy, a gastrostomy to ensure optimization of patient’s nutrional status allowing 
the patient to be considered as a candidate for surgery. 
On the other hand, patients with morbid obesity usually present with associated comorbidities at 
the time of evaluation and surgery. They are considered high-risk patients and should be evaluated 
thoroughly before their operation using a multidisciplinary team approach to select appropriate candi-
dates.13 In the late 1980s, LSG has been proposed as a step procedure in high-risk patients, followed 
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by a second step Roux-en-Y gastric bypass or biliopancreatic diversion and duodenal switch.160,161 
It must be noted in this context that the primary limiting factor in surgery in the super-obese is the 
volume of the left lobe of the liver: a greatly thickened left lobe diminishes and/or impedes visualization of 
the GEJ and His angle. In our center, patients with BMI >45 kg/m2 and/or hepatomegalia are submitted 
to a high-protein, low-carbohydrate diet one week before surgery in order to reduce hepatic fatty infiltra-
tion and size of left hepatic lobe.162 For this same reason Nguyen et al 163 had proposed a staged Roux-
en-Y procedure with a low GJA and a larger gastric pouch. The low anastomosis obviates the need for 
exposure of the GEJ and His angle. At the second stage procedure, completion sleeve gastrectomy of 
the gastric fundus is performed at an interval of 6-12 months after the first stage operation. 
Regarding the association of anastomotic leak rate and the experience of surgeon, Migita et al 10 
state in their series that the experience of the surgeon was not a significant variable relating to the 
incidence of the anastomotic trouble, nor the development of EJAL. They suggest that skills of 
surgical teams, rather than individual surgeons, are important when considering surgical quality. 
Our group believes that the contributions by industry have been also a decisive factor. The devel-
opment of a triple-staple line device (Echelon ®) which applies the same pressure along the length 
of the cartridge making possible that staple formation is the same in the beginning and in the end 
(figure 32), has been crucial. 
1
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Channel Guide
Figure 32: Parts of a laparoscopic stapler device.
Baker et al 33 evaluated and reviewed different ways to optimize the staple-line strength concluding 
that under-sizing staple cartridge increases the risk for inadequate staple formation or can lead to 
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excessive tissue compression leading to tearing and perforation. They establish that staples of 4.8mm 
should be used on thick stomach because they are designed to be stronger and form longer leg 
lengths. They also suggest that great care must be used in firing the endocutters, avoiding a bunch 
of tissue at the crotch of the stapler. The group insists that surgeon must watch and remove the 
“migratory crotch staple” (figure 33). In their study full-thickness over-sewing past a fixed staple-line 
(figure 34) is not recommended because it may increase the risk of tearing at the point of suture pene-
tration in a distended gastric pouch. This effect is not likely to be significant in low-pressure areas. 
Figure 33: Migratory crotch staple. 33 Figure 34 : Oversewing causing leaks when the pouch 
is distended and suture bowstrings and tears tissue. 33
Moreover, the recent outbreak of unidirectional barbed sutures has been proposed to simplify wall 
and mesentery closure in laparoscopy.67,164–166 Our center has recently published two studies: one 
with the largest series for GJA in LGBP 67 and the first study to describe this suture in laparoscopic 
gastro-intestinal anastomoses.166 Among them, 177 laparoscopic GJA (172 during Roux-en-Y GBP 
and 5 after gastrectomy), 5 EJA, and 22 JJA (4 after small bowel resection and 18 during GBP or 
gastrectomy) were required. Senior and training surgeons performed them. There was no conversion 
to usual sutures. One fistula occurred in an EJA and was managed conservatively. One self-limited 
anastomotic bleeding occurred, and no anastomotic stenosis occurred during 6 months of follow-up 
evaluation. As conclusion, barbed sutures for laparoscopic intestinal anastomosis are safe and repro-
ducible. Therefore barbed sutures have been incorporated systematically in our surgical technique for 
intestinal anastomosis simplifying one of the most complex and time-consuming procedures. The use 
of this thread should not be considered as offsetting the inexperience of the surgeon in laparoscopic 
suturing, but to improve it in an area where exposure and continuous traction are often difficult.167
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Therefore performing an EJA with barbed suture is simplified. There is no standardized technique for 
re-establishment of gastrointestinal continuity after total gastrectomy.166 Bracale et al 82 concluded 
that a laparoscopic intracorporeal side-to-side EJA is a safe and feasible technique. It represents a 
valid method for performing a reconstruction of the digestive tract in laparoscopic surgery after LTG, 
especially in presence of a narrow esophagus. Our group has also published our technique for the 
manual creation of a feasible, safe, tension-free and effective EJA (figure 35). Any surgeon familiar 
with laparoscopic surgery and the principles of oncological resection can perform it. The cost is also 
relatively low because neither a circular stapler nor other special equipment is required.66,67,166,167 
Figure 35 : 95% gastrectomy is performed to reduce comorbities associated to esophago-jejunal anastomosis.
To reduce as much as possible morbid-mortality in EJA for cancer gastric surgery, the recent tendency 
is to take into consideration in selected cases (proximal tumors, poorly differentiated diffuse tumors) the 
near total or 95% oncologic gastrectomy (G95%). Described by japanese authors 168,169 in early 80s, 
actually it has been reconsidered by a laparoscopic approach with promising results.170–172 Our lapa-
roscopic technique (figure 36) has been published not long ago.170 It consists on leaving a little gastric 
pouch 2cm long which permits performing a GJA rather than EJA, expecting to reduce leak rate while, 
at the same time, proximal oncologic resection margins are respected. Compared to 7/8 gastrec-
tomy, G95% allows a complete resection of the fundus and lymphadenectomy of stations 1 and 2. 
This technique achieves good short-term outcomes and good quality of life respecting latest onco-
logical criteria about proximal resection margin resection.167,170,173 
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3 4
5 6
Figure 36: Gastrectomy 95% and steps to make gastro-jejunal anastomosis.
1: Gastric section. 2: Identification and preservation of posterior gastro-phrenic artery 3: Gastro-jejunal anastomosis: 
posterior layer. 4: Verifying previous step. 5: Reinforcement of posterior layer. 6: Gastro-jejunal anastomosis: anterior layer.
As regards bariatric surgery, having a thorough knowledge of anatomy of His angle, performing a 
careful dissection of this area and avoiding strictures by diverting slightly to the left in the last shot 16,160 
are important technical considerations that surgeon must take on account in order to prevent leaks. 
Kravetz et al 174 compared in a retrospective study manual versus mechanical anastomosis in LGBP. 
No difference was appreciated in the anastomotic leak or re-exploration rate with either technique. 
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However, the incidence of anastomotic stricture in their series tended to be lower with a hand-sewn 
technique with lower operative time. 
About reinforcement of staple line in LSG (with suture or Gore® Seamguard®) Dapri et al 175 compared 
between no staple line reinforcement, buttressing of the staple line with Gore® Seamguard® and 
staple line suturing in a prospective and randomized study (n=75). They concluded that no signif-
icant difference was evidenced in terms of postoperative leak between the three techniques of 
LSG and Gore® Seamguard® statistically reduces blood loss during stomach sectioning as well 
as overall blood loss. In the other side, Choi et al 176 in a meta-analysis shows that reinforcing 
staple-line decreases incidence of postoperative leak and overall complications. Nevertheless, like 
other authors 177,178 Choi et al, note that more prospective studies with better evidence are needed. 
Our experience with our standardized technique is that no staple line reinforcement is safe and effec-
tive, with the exception of evidence of active bleeding of the staple-line during surgery. In this case, 
we opt for reinforcement with barbed suture.
In relation to the use of fibrin sealants in the prevention of GJAL nowadays there is no clear evidence 
supporting this use.59,121 
Intraoperative leak assessment using endoscopy and/or distension of the anastomosis with dye, air 
or other gas might be useful to detect leaks that can be repaired during the procedure. Nishikawa et 
al 179 propose an intra-operative endoscopy after total gastrectomy as a safe and feasible method 
that can accurate significant information to reduce post-operatory leak detecting the default in EJ 
anastomosis. To achieve it, anastomosis is submerged in saline solution, alimentary limb is clamped 
and air is insufflated through the endoscope. Presence or air bubbles around the anastomosis point 
out the possibility of a leak.180 The last ASMBS guideline concluded that these techniques have not 
been shown to decrease the risk of leak after surgery.121
Another controversial point is placement of prophylactic drains.2 Although some surgeons have advo-
cated routine placement of drains in proximity to the anastomosis to better diagnose and/or control 
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leakage others have supported that they are unnecessary and might increase the risk of a leak devel-
oping.121 Therefore we place them routinely after cancer surgery and selectively after benign surgery.
To conclude this point, it is worth mentioning the study by Haga et al 181 where a prediction scoring 
system of anastomotic leak, “Estimation of Physiologic Ability and Surgical Stress” (E-PASS), is analyzed 
prospectively. It concludes that, requiring only nine variables, this method may be useful in predicting 
anastomotic leak and its prognosis in various kinds of gastrointestinal surgical procedures. The disadvan-
tage is that this formula is not easily applicable in the bedside of the patient given that 9 variables have to 
be collected (age, presence of severe heart disease, severe pulmonary disease, diabetes, performance 
status scale, ASA score, blood loss related to weight, operative time, length of cutaneous incision).
4.5. LIMITATIONS OF THE STUDY
This study has several limitations. First the small number of patients with IAAL included in this study 
is small, but when referred to the number of patients who underwent UGI surgery in our center, 
we think that results must be, al least, considered. Therefore, the level of evidence extracted from 
our study is not as strong as the level of evidence from prospective, randomized, controlled trials; 
however, due to the limited number of patients, this is unlikely to occur, since to detect a 10% reduc-
tion in hospital stay, for example, thousands of patients per arm would be needed.
Second, given the retrospective nature of our study, the potential for selection bias is a possibility. 
In addition, a variety of surgical techniques of performing anastomosis have been employed in the 
included studies. In some patients, anastomosis was done in another center, in other cases different 
devices and sutures were used, such as barbed sutures or current sutures or double staple line cartridges. 
Consequently, this could have affected clinical success rate, but also complication and mortality rates. 
Finally, selection bias cannot be excluded in this patient group, as it has still not been elucidated 
which patients could benefit from stenting and which patients from primary surgery. Further random-
ized trials are, however, needed to compare different stent types, on one hand, and the ideal stent 
design that comes out of these trials with surgical treatment, on the other hand.
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4.6. MANAGEMENT ALGORITHM
To conclude, I would like to propose an algorithm for the management of IAAL after UGI surgery (figure. 37). 
Figure 37 : Flowchart proposed for the managment of IAAL.
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Conclusions
1. Although there is a downward trend, intraabdominal anastomotic leak after upper gastrointes-
tinal surgery is a serious complication: efforts must be made to decrease its incidence in order 
to diminish morbi-mortality and the high economic cost to society. 
2. A universally accepted definition of intraabdominal anastomotic leakage after upper gastroin-
testinal surgery is needed, as well as common agreed standardized diagnostic algorithms and 
uniform grading of severity. This may contribute to have uniform criteria that would facilitate 
valid comparison of the results of different studies improving its management.
3. Prevention is our most important asset: patient selection by a multidisciplinary team, adequate 
surgery indication, preoperatory optimization and a standardized surgical technique. 
4. Early diagnosis of intraabdominal anastomotic leak is paramount: it cannot be based on clinical 
suspicion alone. Therefore an endoscopic exploration should be performed when possible 
allowing early diagnosis, providing information of anastomosis’ morphologic characteristics to 
help accurate the best management. Eventually, treatment can be done at the same time. 
5. Multidisciplinary treatment combining endoscopical, surgical (laparoscopic) and radiological 
techniques is the best strategy to reduce time until leak healing. It must be achieved in a 
specialized center: adequate drainage of the abdominal collection, nutritional support and a 
rigorous clinical and radiological follow-up are essential.
6. In hemodynamic stable patients, conservative management can be effective and can obviate 
a reintervention, thereby avoiding postoperative complications. 
7. Surgical management is the definitive treatment in hemodynamic unstable patients. Lapa-
roscopic approach allows evaluation of anastomosis’ characteristics, consents a peritoneal 
lavage and positioning effective drains. Laparotomy remains anecdotal for hemodynamic 
unstable non-responding patients excluded of mini-invasive treatment.
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8. Endoscopical treatment with temporary stent placement and removal with low procedure-related 
morbidity and mortality is feasible and can be a definitive treatment in adequately perfused upper 
gastrointestinal surgery anastomotic leakage. Because of the favorable outcome of stent therapy 
compared with other treatment regimens, we can suggest stent therapy as the treatment of 
choice in this situation.
9. Temporary stent can help cronify a leak until a definitive surgery can be performed in an optimal 
clinical and nutritional status of the patient.
10.  However, because stent migration remains a common problem in postoperative patients, the 
optimal type of stent, the best time for stent removal, and useful additional endoscopic means 
for stent fixation have yet to be defined in these patients. 
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Conclusiones
1. A pesar de que hay una tendencia decreciente, la IAAL tras la cirugía supramesocólica es 
una complicación seria: se deben dirigir los esfuerzos a disminuir su incidencia y así rebajar la 
morbi-mortalidad y el alto coste económico que ello supone a la sociedad.
2. Es necesario una definición universalmente aceptada de dehiscencia anastomótica intraab-
dominal tras cirugía supramesocólica, así como algoritmos de diagnóstico comunes, acor-
dados y estandarizados y un sistema de clasificación de severidad uniforme. Ello puede 
contribuir a tener un criterio equiparable que facilite una comparación válida de resultados 
entre diferentes estudios, mejorando de este modo su manejo.
3. La prevención es la mejor herramienta: la selección de paciente por un equipo multidisciplinar, 
una adecuada indicación quirúrgica, la optimización preoperatoria y una técnica quirúrgica 
estandarizada.
4. El diagnóstico precoz es sumamente importante: no puede basarse tan solo en la sospecha 
clínica. Por eso se debería realizar un exploración endoscópica que permita el diagnóstico 
temprano, al mismo tiempo que da información de las características morfológicas de la anas-
tomosis que permitirá el manejo más adecuado.
5. El tratamiento multidisciplinar combinando técnicas endoscópicas, quirúrgicas y radiológicas 
es la mejor estrategia para reducir el tiempo hasta el sellado. Debe de llevarse a cabo en 
centros especializados siendo esenciales un drenaje adecuado de la colección intraabdom-
inal, soporte nutricional y un seguimiento estrecho clínico-radiológico.
6. En pacientes con estabilidad hemodinámica el manejo conservador puede ser efectivo y evitar 
la reintervención y evitando por lo tanto las complicaciones postoperatorias.
7. El manejo quirúrgico es el tratamiento definitivo en pacientes con inestabilidad hemodinámica. 
El abordaje laparoscópico consiente la evaluación de las características de la anastomosis, 
permite el lavado de la cavidad peritoneal y la colocación de drenajes efectivos.  La laparotomía 
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se limita a casos anecdóticos, pacientes inestables no respondedores excluidos del trata-
miento mini-invasivo.
8. El tratamiento endoscópico de un stent temporal y su retirada, teniendo este procedimiento 
una baja morbi-mortalidad, hace que sea factible y que pueda ser el tratamiento definitivo en 
IAAL con  una buena perfusión. Debido al resultado favorable del tratamiento con stent frente 
a otros tratamientos, podemos sugerir el stent como tratamiento de elección en esta situación.
9. Un stent temporal puede cronificar la dehiscencia hasta poder instaurar un tratamiento quirúr-
gico definitivo cuando las condiciones clínicas y nutricionales del paciente lo permitan. 
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Appendix A - Classification of surgical complications Clavien-Dindo 63
Grade Definition
I
Any deviation from the normal postoperative course without the need for pharmacological 
treatment or surgical, endoscopic, and radiological interventions. 
Allowed therapeutic regimens are: drugs (antiemetics, antipyretics, analgesics, diuretics, 
electrolytes, physiotherapy). This grade also includes wound infections opened at the bedside.
II
Requiring pharmacological treatment with drugs other than such allowed for grade I complications. 
Blood transfusions and total parenteral nutrition are included.
III Requiring surgical, endoscopic or radiological intervention.
IIIa Interventions not under general anesthesia.
IIIb Interventions under general anesthesia.
IV Life-threatening complication (including CNS complications) requiring IC/ICU management.
IVa Single organ dysfunction (including dialysis).
IVb Multiorganic dysfunction.
V Death of a patient.
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